Highlights of the 2nd European Lung Cancer Conference.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 5, p. 297, doi. 10.1177/1758834010374727
- By:
- Publication type:
- Article
Works matching IS 17588340 AND DT 2010 AND VI 2 AND IP 5
Results: 5
1
2
The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 5, p. 301, doi. 10.1177/1758834010370698
- By:
- Publication type:
- Article
3
Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 5, p. 331, doi. 10.1177/1758834010376301
- By:
- Publication type:
- Article
4
Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 5, p. 319, doi. 10.1177/1758834010375759
- By:
- Publication type:
- Article
5
Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity.
- Published in:
- Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 5, p. 309, doi. 10.1177/1758834010375096
- By:
- Publication type:
- Article